UK Cancer Deaths Fall 29% Since 1980s, But Challenges Remain | Cancer Research UK

0 comments

Cancer Death Rates in the UK Reach Historic Low, Despite Rising Diagnoses

The rate of people dying from cancer in the UK has fallen by almost a third since the 1980s, marking a significant victory in cancer care and research. However, rising diagnoses due to an aging population mean the overall number of cancer deaths remains substantial, prompting continued calls for investment in cancer services.

Significant Decline in Cancer Mortality

Approximately 247 out of every 100,000 people in the UK die from cancer each year, a 29% decrease from the peak of 355 per 100,000 in 1989 Cancer Research UK (CRUK). Over the past decade alone, cancer death rates have fallen by 11% The Independent.

Specific Cancer Types Show Marked Improvement

The decline in mortality rates is not uniform across all cancer types. Significant reductions have been observed in:

  • Ovarian cancer: 19% decrease (2012-2014 to 2022-2024)
  • Stomach cancer: 34% decrease
  • Lung cancer: 22% decrease
  • Breast cancer: 14% decrease
  • Cervical cancer: 11% decrease
  • Leukaemia: 9% decrease
  • Oesophageal cancer: 12% decrease

Notably, cervical cancer death rates have fallen by 75% since the 1970s, largely due to the NHS cervical screening programme and the widespread adoption of the human papillomavirus (HPV) vaccine, with over 6.5 million people vaccinated since 2008 The Independent.

Areas of Concern: Rising Rates in Certain Cancers

While overall death rates are declining, some cancer types have seen an increase in mortality over the last decade:

  • Kidney cancer: 5% increase
  • Liver cancer: 14% increase
  • Eye cancer: 26% increase
  • Gallbladder cancer: 29% increase

Death rates for thyroid, pancreatic, and melanoma cancers have remained stable.

Factors Contributing to the Decline

Cancer Research UK attributes the falling death rates to several key factors, including smoking bans, the rollout of screening programs for breast, bowel, and cervical cancers, and advancements in treatment. New treatments, such as abiraterone for prostate cancer, developed by CRUK scientists, have also contributed to improved outcomes.

Challenges Remain: Rising Diagnoses and NHS Pressures

Despite the positive trends, cancer remains Britain’s biggest killer, accounting for about one in four deaths. A growing and aging population means that more people are being diagnosed with cancer – approximately one person every 75 seconds in the UK. This increase in diagnoses means the overall number of cancer deaths continues to rise.

the NHS faces ongoing challenges in delivering cancer care, with many trusts failing to meet performance targets. The government has pledged £2 billion to improve cancer diagnosis and treatment by 2029, but significant improvements are still needed.

Key Takeaways

  • Cancer death rates in the UK have fallen significantly since the 1980s.
  • Improvements are seen in mortality rates for several major cancer types.
  • Rising diagnoses due to an aging population mean the overall number of cancer deaths remains high.
  • Continued investment in research, screening, and treatment is crucial.

Related Posts

Leave a Comment